Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis—A real-world case seriesChristopher Dietz-Fricke, Pietro Lampertico, Julia M. Grottenthaler et al.|Hepatology|2024Cited by 36
Sex, Genotype, and Liver Volume Progression as Risk of Hospitalization Determinants in Autosomal Dominant Polycystic Liver DiseaseRia Schönauer, Michael P. Mueller, Melis Kayikci et al.|Gastroenterology|2023Cited by 6
Combined Consideration of Sex, Genotype, and Total Liver Volume Progression Determines the Risk of Hospitalization in an International Multicenter Cohort of Autosomal Dominant Polycystic Liver DiseaseDana Sierks, Jan Halbritter, Peter C. Harris et al.|Journal of the American Society of Nephrology|2023Cited by 0